선천성 횡격막 탈장에서 생리학적 기반 코드 클램핑 (PinC)
선천성 횡격막 탈장을 가지고 태어난 영아를 위한 생리학적 기반 탯줄 고정 대 즉각적인 탯줄 고정: 다기관 무작위 대조 시험
Pulmonary hypertension is a major determinant of postnatal survival in infants with a congenital diaphragmatic hernia (CDH). The current care during the perinatal stabilisation period in infants born with this rare birth defect might contribute to the development of pulmonary hypertension after birth - in particular umbilical cord clamping before lung aeration. An ovine model of diaphragmatic hernia demonstrated that cord clamping after lung aeration, called physiological-based cord clamping (PBCC), avoided the initial high pressures in the lung vasculature while maintaining adequate blood flow, thereby avoiding vascular remodelling and aggravation of pulmonary hypertension. The investigators aim to investigate if the implementation of PBCC in the perinatal stabilisation period of infants born with a CDH could reduce the incidence of pulmonary hypertension in the first 24 hours after birth.
The investigators will perform a multicentre, randomised controlled trial in infants with an isolated CDH. Before birth, infants will be randomised to either PBCC or immediate cord clamping, stratified by treatment centre and severity of pulmonary hypoplasia on antenatal ultrasound. For performing PBCC a purpose-designed resuscitation module (the Concord Birth Trolley) will be used.
연구 개요
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Nijmegen, 네덜란드
- Radboudumc University Medical Center
-
Rotterdam, 네덜란드
- Erasmus MC University Medical Center - Sophia Children's Hospital
-
-
-
-
-
Bonn, 독일
- Universitätskrankenhaus Bonn
-
Mannheim, 독일
- Universitätsklinik Mannheim
-
-
-
-
-
Leuven, 벨기에
- University Hospitals leuven
-
-
-
-
-
Stockholm, 스웨덴
- Karolinska University Hospital
-
-
-
-
-
Graz, 오스트리아
- Medical University Graz
-
-
-
-
-
Rome, 이탈리아
- Ospedale Pediatrico Bambino Gesu
-
-
-
-
-
Melbourne, 호주
- Monash University
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Left-sided CDH
- Isolated CDH: no associated structural or genetic abnormalities that are diagnosed before birth
- Gestational age at delivery ≥35.0 weeks
- Parental written informed consent
Exclusion Criteria:
- Right-sided or bilateral CDH
- Gestational age at delivery <35.0 weeks
- Maternal contraindications: anterior placenta praevia, placental abruption
- High urgency caesarean section, with intended interval to delivery <15 min
- Cases that have been treated during pregnancy with experimental drug therapy aiming to decrease the occurrence of pulmonary hypertension
- Twin pregnancies in which the infant diagnosed with a CDH is born first
- Multiple birth >2 (triplets or higher order)
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 방지
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Physiological-based cord clamping
In PBCC, the Concord will be placed next to the bed of the mother and all equipment will be checked before the second stage of labour has started. The infant will be placed on the platform of the Concord immediately after birth, avoiding any traction or pressure on the cord and avoiding heat loss by radiation heating. The umbilical cord will not be clamped until the infant is considered respiratory stable, which is defined as the presence of a heart rate >100 bpm and preductal oxygen saturation >85%, while using an fraction of inspired oxygen (FiO2) of <0.5. The minimum and maximum times of cord clamping are three and ten minutes after birth, respectively. Oxytocin administration will be postponed until after cord clamping if there are no obstetric concerns. At any time, the attending neonatologist and obstetrician can decide that PBCC should not be performed or be interrupted. In that case, the infant can be placed on the standard resuscitation table for (further) stabilisation. |
See 'Arm' |
|
간섭 없음: Immediate cord clamping
In the immediate cord clamping group, the cord will be clamped immediately after birth. The infant will then be transferred to the standard neonatal resuscitation table. After cord clamping, all infants will be managed according to the standardised neonatal management protocol for infants with a CDH, which is a consensus of current clinical guidelines by the CDH EURO consortium. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Number of participants with pulmonary hypertension diagnosed in the first 24 hours after birth.
기간: First 24 hours after birth
|
Pulmonary hypertension is present if at least 2 of the following 4 criteria are present or if the infant requires extracorporeal membrane oxygenation (ECMO) in the first 24 hours after birth:
The following echocardiographic parameters will be collected to objectify these criteria:
|
First 24 hours after birth
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Neonatal: mortality before discharge from the tertiary care hospital
기간: From birth till discharge from the tertiary care hospital, through study completion an average of one year
|
Number of patients that died before discharge |
From birth till discharge from the tertiary care hospital, through study completion an average of one year
|
|
Neonatal: presence of 3 or more criteria for pulmonary hypertension or extracorporeal membrane oxygenation within 24 hours after birth
기간: The first 24 hours after delivery
|
Number of patients with 3 or more criteria or ECMO |
The first 24 hours after delivery
|
|
Neonatal: number of patients requiring ECMO therapy
기간: From admission to the ICU until the date of death or the date of discharge home, whichever came first
|
Number of patients requiring ECMO therapy |
From admission to the ICU until the date of death or the date of discharge home, whichever came first
|
|
Neonatal: number of days of duration of supplemental oxygen need
기간: From admission to the ICU until the date of discharge to another ward or home, whichever came first,through study completion an average of one year
|
Number of days of duration of supplemental oxygen need |
From admission to the ICU until the date of discharge to another ward or home, whichever came first,through study completion an average of one year
|
|
Neonatal: number of days of duration of mechanical ventilation
기간: From admission to the ICU until the date of discharge to another ward or home, whichever came first,through study completion an average of one year
|
Number of days of duration of mechanical ventilation |
From admission to the ICU until the date of discharge to another ward or home, whichever came first,through study completion an average of one year
|
|
Neonatal: duration of admission to the tertiary care hospital
기간: From admission to the ICU until the date of discharge to another ward or home, whichever came first
|
Number of days of admission to the tertiary care hospital |
From admission to the ICU until the date of discharge to another ward or home, whichever came first
|
|
Maternal: number of patients with postpartum haemorrhage
기간: The first 24 hours after delivery
|
Postpartum haemorrhage is defined as estimated blood loss >1000 mL |
The first 24 hours after delivery
|
공동 작업자 및 조사자
간행물 및 유용한 링크
일반 간행물
- Horn-Oudshoorn EJJ, Knol R, Vermeulen MJ, Te Pas AB, Hooper SB, Cochius-den Otter SCM, Wijnen RMH, Crossley KJ, Rafat N, Schaible T, de Boode WP, Debeer A, Urlesberger B, Roberts CT, Kipfmueller F, Reiss IKM, DeKoninck PLJ. Physiological-based cord clamping versus immediate cord clamping for infants born with a congenital diaphragmatic hernia (PinC): study protocol for a multicentre, randomised controlled trial. BMJ Open. 2022 Mar 18;12(3):e054808. doi: 10.1136/bmjopen-2021-054808.
- Horn-Oudshoorn EJJ, Vermeulen MJ, Knol R, Bout-Rebel R, Te Pas AB, Hooper SB, Otter SCMC, Wijnen RMH, Crossley KJ, Rafat N, Schaible T, de Boode WP, Debeer A, Urlesberger B, Roberts CT, Kipfmueller F, Capolupo I, Burgos CM, Hansen BE, Reiss IKM, DeKoninck PLJ. Multicentre, randomised controlled trial of physiological-based cord clamping versus immediate cord clamping in infants with a congenital diaphragmatic hernia (PinC): statistical analysis plan. Trials. 2024 Mar 20;25(1):198. doi: 10.1186/s13063-024-08027-7.
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- PinC CDH trial
- NL7853 (레지스트리 식별자: NTR)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .